American Bio Medica Corp
OTC:ABMC
American Bio Medica Corp
OTC:ABMC
Price:
0.0001
USD
Market Cap:
$48.1
Balance Sheet
Balance Sheet Decomposition
American Bio Medica Corp
American Bio Medica Corp
Balance Sheet Decomposition is not available for
American Bio Medica Corp
American Bio Medica Corp
Balance Sheet
American Bio Medica Corp
American Bio Medica Corp
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
4
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
5
N/A
|
4
-18%
|
4
-10%
|
3
-9%
|
3
-14%
|
2
-14%
|
2
-16%
|
2
-7%
|
2
-2%
|
1
-33%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Total Current Liabilities |
3
|
3
|
2
|
2
|
1
|
2
|
2
|
2
|
3
|
4
|
|
| Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
3
-14%
|
3
-12%
|
2
-14%
|
2
-3%
|
3
+16%
|
3
+9%
|
3
+11%
|
3
-11%
|
4
+28%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
19
|
20
|
20
|
20
|
21
|
22
|
23
|
23
|
24
|
25
|
|
| Additional Paid In Capital |
20
|
20
|
21
|
21
|
21
|
21
|
21
|
22
|
23
|
22
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
1
N/A
|
1
-28%
|
1
-1%
|
1
+7%
|
1
-39%
|
0
N/A
|
1
-441%
|
1
-59%
|
1
+25%
|
2
-148%
|
|
| Total Liabilities & Equity |
5
N/A
|
4
-18%
|
4
-10%
|
3
-9%
|
3
-14%
|
2
-14%
|
2
-16%
|
2
-7%
|
2
-2%
|
1
-33%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
23
|
24
|
26
|
29
|
30
|
32
|
33
|
38
|
48
|
48
|
|
Switch to:
Switch to:
See Also
Discover More
